Skip Quick Links
Quick Links
Skip Banners
Inner left 2
Inner left 3
Inner left 1

Helsinki Committee

Committee Members

Prof. Sternberg Ehud – Committee Chairperson/Department Head 

Prof. Wiener Paltiel – Deputy Committee Chairperson/Department Head/Internist 

Dr. Ofir Avinoam – Deputy Committee Chairperson/Department Head 

Dr. Bader Tarif ­– Management Representative 

Dr. Mickey Dudkevich – Management Representative  

Dr. Yerchovsky Yaakov – Department Head/Internist 

Prof. Groissman Gavriel – Department Head 

Dr. Noa Berer-Yanai – Department Head/Internist  

Dr. Ronit Rachmilevitz – Department head/Internist 

Dr. Nisipeanu Piu – Committee member 

Dr. Simcha Meisel – Committee member 

Dr. Micha Levi – Committee member/Internist 

Dr. Eyal Schwartzberg – Committee member/Pharmacy Manager 

Majr Kamal Amarne – Committee member/Pharmacist 

Adv. Esther Hagar – Representative of the Public  

Adv. Shlomo Nesher – Representative of the Public 

Adv. Nachum Yitchaki – Representative of the Public 

Adv. Philip Feinberg – Representative of the Public 

Mrs. Reuma Barkan - Committee Coordinator 

Mrs. Sharon Lavie – Assistant Committee Coordinator 


Submission of research proposals for Helisnki Committee approval will be accepted through the Matarot program only. 

Back to top Back to top

About The Committee

The Helsinki Committee deals with research approval and human experiments. Their purpose is to expand medical knowledge and improve the results of medical treatments.  


For this purpose, the Helsinki Committee serves first and foremost as a servant of the public, and operates mainly to ensure the wellbeing and rights of experiment participants and subjects, and to ensure that the research/experiment is conducted in accordance with the approved medical guidelines and ethics, which are in accordance with the guidelines outlined in the Declaration of Helsinki and the various international conventions concerning medical experiments on humans, and in accordance with the guidelines, laws and regulations which were legislated by the Israeli parliament and the ministry of health with the aim of regulating the issue of medical experiments on humans.  


The work of the Helsinki Committee is conducted in a manner that ensures the integrity of research/experiment proposals submitted to the committee, and the proper conduction of deliberations concerning each request. The committee will approve or reject proposals after deliberation and voting; proposals that are deemed proper by the committee, and are designated as “special experiments”, will be deferred to the general medical manager for approval, and those proposals,designated as “other experiments”, will be deferred to the ministry of health in Jerusalem for approval. The committee will receive reports with relation to unusual occurrences and side effects, observed during the course of the experiment, from the researchers, and will deliberate the implications with relation to the continuation of the experiments. The committee will discuss changes in protocol and the implications on the continuation of the experiment, and in accordance with its conclusions, will decide whether or not to approve the changes. The committee will deliberate approval extension requests for performing research/experiments, and this will occur only after deliberating the research’s interim progress report . The committee will receive final summarizing reports at the end of each experiment. The committee will transfer real-time reports to the ministry of health after each and every one of its meetings, as well as yearly or periodical reports as requested from time to time. In addition to the above, the committee will deliberate requests for experimental treatments whose purpose is to save the life of an individual patient.

Back to top Back to top

Useful Information


Management offices, research fund office  


Telephone Number 

04-7744304 (main calling center), 04-7744223 


Fax number 





Mailing Address 

Research fund, Hillel Yaffe Medical Center, P.O. Box 169, Hadera 38100 


Confirmation ICH GCP (renewed once a year) 

Click here to download the declaration confirming that the Helsinki Committee operates according to the ICH GCP guidelines 
Back to top Back to top

The Matarot Program

A software program for management and supervision of the Helsinki Committee 


  • A professional information system that serves to manage and regulate theHelsinki Committee’s medical research. 
  • The system serves the following relevant people: researchers, Helsinki Committee members, the management of the medical institution and supervising bodies.
  • The system follows the research processes from managerial and ethical aspects as defined by the standards of the ministry of health, and monitors them.
  • The system accompanies the research from the initial appeal step, to the approval of the research by the committee, and to the finalization of the research.  


*Forms must be submitted through the Matarot program, in addition, three printed and signed copies must be submitted to the committee coordinators. 

*The conventions for drafting medical experiments can be found on the NIH website 

Back to top Back to top

Payment Guidelines

  • Institutional applications submitted for approval of clinical research to the Helsinki Committee initiated by commercial companies – the company must pay the processing fees upon submitting the application. 
  • The committee does not guarantee application approval.

Payment Fees 

  • New application: $800 
  • Continuation of research/secondary research projects: No charge. 
  • Extension of research period/change of protocol: No charge. 
  • Changes in the investigator’s brochure and consent forms: No charge.  

(Fees will be updated from time to time) 

Back to top Back to top
Skip Banners
Nursing school
Skip Banners
Skip Banners
health tip
Skip Banners
Skip Banners
Alternative Medicine
דרונט בניית אתרים
Skip Bottom bar
Bottom bar
Content Management:
Jump to page content